DCF — AHN THE MEDICAL CENTER
Enterprise Value: $-166.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-166.0M
Enterprise Value
$-73.0M
PV of Cash Flows
$-93.0M
PV of Terminal Value
$-149.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $790.3M | $3.3M | 0.0% | $-30.2M | $-27.4M |
| Year 2 | $814.0M | $11.5M | 1.0% | $-22.9M | $-18.9M |
| Year 3 | $838.4M | $20.3M | 2.0% | $-15.2M | $-11.4M |
| Year 4 | $863.6M | $25.2M | 3.0% | $-12.3M | $-8.4M |
| Year 5 | $889.5M | $28.2M | 3.0% | $-11.0M | $-6.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-166.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$767.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0008252399426892725
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5